Sanofi inks US$1.2 billion vaccine licensing deal with Novavax
Sanofi and Novavax signed a licensing agreement that includes commercialising a combined Covid-19 and flu shot. Novavax will receive US$500 million ...
Sanofi and Novavax signed a licensing agreement that includes commercialising a combined Covid-19 and flu shot. Novavax will receive US$500 million ...
Forbes 40under40 stands as a distinguished platform revered for its commitment to honoring and applauding the remarkable achievements of exceptional individuals who have yet to reach the age of 40. This esteemed initiative serves as a beacon of inspiration, spotlighting trailblazers across various industries and domains, showcasing their innovation, leadership, and impact on a global scale.
© 2024 Forbes 40under40. All Rights Reserved.